Juniper Biosciences Announces Strategic Collaboration with leading global cancer center on F-MISO (JBS-003)

The Faces Behind Our Science

Combining targeted diagnostics and therapeutic delivery to improve outcomes in oncology.

Alex Agnoletto

CEO, Co-Founder & Board Member

Dr. Indranil Nandi, PhD

COO & Co-Founder

Dr. Kyle Hoffmann, PharmD

Director of Manufacturing, Co-Founder

Dr. Serge Lyashchenko, PharmD

Advisor, Co-Founder & Board Member

Sharon Roded

Advisor, Co-Founder, Board Member

Pietro Bubba Bello

Advisor, Board Member

What's New

Upsized and Oversubscribed Seed Round Completed at $40 Million

Juniper Biosciences LLC today announced the closing of an oversubscribed and upsized $40 million seed financing through its parent company, Juniper Radiopharma LLC…